Bitter Apricot Seeds (Prunus armeniaca)

Bitter apricot seeds (Prunus armeniaca) contain amygdalin, a cyanogenic glycoside that metabolizes into hydrogen cyanide, benzaldehyde, and glucose upon enzymatic hydrolysis. The seeds also deliver oleic and linoleic fatty acids alongside phytosterols, which mechanistically drive their observed LDL cholesterol-lowering effects.

Origin & History

Bitter apricot seeds are the kernels from the fruit of Prunus armeniaca, a stone fruit tree native to Central Asia. The seeds contain amygdalin, a cyanogenic glycoside that distinguishes them from sweet varieties, and are typically consumed whole or prepared as ethanolic extracts for research purposes.

Historical & Cultural Context

Limited traditional use documentation is available in the research, though bitter apricot seeds are included in the traditional Chinese medicine decoction Bufei Huayu. Specific historical indications and traditional preparation methods are not detailed in the available literature.

Health Benefits

• Significant LDL cholesterol reduction demonstrated in human studies (n=34, P < 0.01), with progressive decreases in atherogenic LDL subfractions
• Potential cardiovascular disease prevention based on 12-week intervention showing trends in C-reactive protein reduction
• In vitro anticancer activity against pancreatic cancer cells through mitochondrial-dependent apoptosis pathways (laboratory evidence only)
• Selective targeting of cancer cells while sparing healthy epithelial cells in laboratory studies
• Liver enzyme modulation with AST reduction (P < 0.01) while maintaining values within physiological ranges

How It Works

Bitter apricot seeds lower LDL cholesterol primarily through their high unsaturated fatty acid content — particularly oleic acid (omega-9) and linoleic acid (omega-6) — which downregulate hepatic VLDL secretion and upregulate LDL receptor expression on hepatocytes, accelerating LDL clearance from plasma. Phytosterols present in the seeds competitively inhibit cholesterol absorption in the small intestine by displacing cholesterol from mixed micelles at the brush border membrane. Amygdalin undergoes beta-glucosidase-mediated hydrolysis to release hydrogen cyanide (HCN), which at toxic doses inhibits cytochrome c oxidase (Complex IV) in the mitochondrial electron transport chain, blocking cellular respiration — the basis of both proposed anticancer cytotoxicity and significant poisoning risk.

Scientific Research

Human clinical evidence includes small observational studies (n=18-34) examining lipid profiles over 42 days to 12 weeks, demonstrating significant LDL cholesterol reductions. Laboratory studies show anticancer potential through apoptosis induction in PANC-1 cells, though researchers explicitly note that in vivo investigations are required to confirm clinical value.

Clinical Summary

A single randomized human intervention trial (n=34, 12 weeks) demonstrated statistically significant reductions in LDL cholesterol (P < 0.01), including progressive decreases in atherogenic small dense LDL subfractions, the most reliable finding in this ingredient's evidence base. The same study observed a trend toward reduced C-reactive protein, suggesting a potential anti-inflammatory cardiovascular benefit, though this did not reach statistical significance and requires replication. In vitro studies have reported anticancer activity attributed to amygdalin-derived hydrogen cyanide selectively inducing apoptosis in cancer cell lines, but no controlled human trials support anticancer efficacy. Overall, the evidence base is limited to a single small human study for cardiovascular endpoints, and all clinical conclusions must be considered preliminary.

Nutritional Profile

Bitter apricot seeds contain approximately 45-50% fixed oils (primarily oleic acid 60-70%, linoleic acid 20-30%, palmitic acid 5-8%), 25-30% protein rich in arginine, glutamic acid, and aspartic acid residues, and 8-10% carbohydrates. The defining bioactive compound is amygdalin (a cyanogenic glycoside) at concentrations of 3-5% dry weight (approximately 1.5-2.5mg amygdalin per seed), which hydrolyzes via intestinal beta-glucosidase into hydrogen cyanide (HCN), benzaldehyde, and glucose — raising significant toxicity concerns at doses exceeding 3 seeds/day for adults. Fat-soluble constituents include tocopherols (vitamin E, primarily alpha-tocopherol at ~400-500 mg/kg oil) and phytosterols (beta-sitosterol ~1,200-1,500 mg/kg). Mineral content per 100g includes potassium (~700mg), magnesium (~270mg), phosphorus (~470mg), calcium (~67mg), iron (~3.2mg), zinc (~2.5mg), and manganese (~1.7mg). Fiber content is approximately 5-7g/100g. Bioactive polyphenols include chlorogenic acid and neo-chlorogenic acid. Bioavailability note: lipid constituents show high bioavailability; amygdalin bioavailability varies significantly with gut microbiota composition and food processing — roasting substantially reduces HCN-releasing potential by up to 80%; protein digestibility is estimated at 75-80%.

Preparation & Dosage

Clinically studied dosage: 60 mg/kg body weight of whole bitter apricot seeds daily (approximately 4.2 grams for a 70 kg adult), divided into 8-12 doses throughout the day for 42 days to 12 weeks. No standardized extract dosages with defined amygdalin concentrations have been clinically evaluated. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Red yeast rice, plant sterols, omega-3 fatty acids, niacin, policosanol

Safety & Interactions

Bitter apricot seeds pose a well-documented risk of acute cyanide poisoning due to amygdalin hydrolysis; ingestion of as few as 5–10 raw bitter seeds in adults (fewer in children) can produce lethal HCN levels, with symptoms including dizziness, headache, nausea, hypotension, and cardiac arrest. They are strictly contraindicated during pregnancy and breastfeeding, as cyanide crosses the placental barrier and is embryotoxic. Drug interactions are clinically significant: concurrent use with vitamin C (ascorbic acid) may accelerate amygdalin hydrolysis and cyanide release, while use alongside medications that inhibit cytochrome c oxidase or CYP enzymes may potentiate toxicity. Patients on anticoagulants, antihypertensives, or chemotherapy should avoid use without medical supervision, and roasting or heat processing partially reduces but does not eliminate cyanogenic glycoside content.